The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of Iowa has found.

High blood pressure silently damages vital organs without obvious symptoms, earning its reputation as a "silent killer." While millions receive prescriptions ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...

Jan. 27, 2025 — Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team has ... Jan. 23, 2025 — New research looked at how cancers arise in children ...

The risk of dissection with a protection device is negligible, but one has to consider the possibility of spasm, which is usually treatable with medication. The indications for renal protection ...

is likely to offer additional protection against heart and kidney disease in patients with diabetes. Findings were published today in The Lancet Diabetes & Endocrinology and presented in May at ...